secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nu-Med Plus, Inc. (NUMD)
CIK:        0001543637
Form:       8-K
Filed at:   2026-10-20T12:56:16+00:00
Accession:  0001575872-26-000709
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Nu-Med Plus raises $450,000 selling 171,232 Series A Preferred at $2.628; conversion equals 3.42M common
--------------------------------------------------------------------------------

- Two accredited investors bought 171,232 shares of Series A Preferred at $2.628 per share for aggregate proceeds of $450,000 on Oct 19, 2026.
- Investors got piggy-back registration rights to include conversion shares in any resale registration statement the company files within two years.
- Full conversion of the investors' preferred would yield 3,424,640 common shares; a consultant's 50,000 preferred converts into 1,000,000 common shares.
- The company issued the consultant 50,000 Series A Preferred for services rendered and paid no sales commissions on any of the sales.
- Offering is best-efforts with no minimum, capped at 190,258 shares or $500,000, ending Oct 30, 2026 unless the board extends up to 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1543637/000157587226000709/0001575872-26-000709-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1543637/000157587226000709/numd_8k.htm
  HTML page:      https://secwatch.observer/filing/0001575872-26-000709

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer